ALLMedicine Deep Vein Thrombosis Center

May 31st, 2020 - COVID-19 may predispose patients to an increased risk of thrombotic complications through various pathophysiological mechanisms. Most of the reports on a high incidence of thrombotic complications are in relation to deep vein thrombosis and pulmon...

May 30th, 2020 - COVID 19 predispose to deep vein thrombosis . We describe an early placement of inferior vena cava filter added to the therapeutic anticoagulation to prevent a massive pulmonary embolism.

May 28th, 2020 - A deep vein thrombosis in a young man.|2020|Tinti MG,Pazienza L,Santoliquido MT,D'Amico G,Carnevale V,|

May 27th, 2020 - Rivaroxaban, a novel oral anticoagulant drug, is widely used in clinical practice. There is no standardized laboratory monitoring for rivaroxaban, and its plasma concentration in Chinese patients with deep vein thrombosis is unclear. The rivaroxab...

May 25th, 2020 - Deep vein thrombosis and pulmonary embolism, collectively defined as venous thromboembolism (VTE), are the third leading cause of cardiovascular death in the United States. Common genetic variants conferring increased varying degrees of VTE risk h...

May 5th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

May 5th, 2020 - This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is the most appropriate imaging modality to assess upper-extremity deep vein thrombosis. It i...

Jan 13th, 2020 - The purpose of this study was to measure the prevalence of MetS in patients with deep vein thrombosis (DVT) across a large population and determine its effect on VTE recurrence.

Jan 31st, 2019 - The prevalence of deep venous thrombosis in patients with advanced cancer is unconfirmed and it is unknown whether current international thromboprophylaxis guidance is applicable to this population. We aimed to determine prevalence and predictors ...

Nov 5th, 2018 - Suspected lower extremity deep venous thrombosis is a common clinical scenario which providers seek a reliable test to guide management. The importance of confidently making this diagnosis lies in the 50% to 60% risk of pulmonary embolism with unt...

May 31st, 2020 - COVID-19 may predispose patients to an increased risk of thrombotic complications through various pathophysiological mechanisms. Most of the reports on a high incidence of thrombotic complications are in relation to deep vein thrombosis and pulmon...

May 30th, 2020 - COVID 19 predispose to deep vein thrombosis . We describe an early placement of inferior vena cava filter added to the therapeutic anticoagulation to prevent a massive pulmonary embolism.

May 28th, 2020 - A deep vein thrombosis in a young man.|2020|Tinti MG,Pazienza L,Santoliquido MT,D'Amico G,Carnevale V,|

May 28th, 2020 - Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mob...

May 27th, 2020 - Rivaroxaban, a novel oral anticoagulant drug, is widely used in clinical practice. There is no standardized laboratory monitoring for rivaroxaban, and its plasma concentration in Chinese patients with deep vein thrombosis is unclear. The rivaroxab...

Mar 16th, 2020 - The spectrum of venous thromboembolism (VTE) comprises both deep vein thrombosis (DVT) and pulmonary embolism (PE). The manifestation of these diseases covers a wide range, from clinically silent to massive embolism causing death. Thromboembolic d...

Jan 13th, 2020 - The purpose of this study was to measure the prevalence of MetS in patients with deep vein thrombosis (DVT) across a large population and determine its effect on VTE recurrence.

Dec 30th, 2019 - NEW YORK (Reuters Health) - Bariatric surgery is associated with a significant decrease in the long-term risk of venous thromboembolic events (VTEs), principally deep vein thrombosis (DVT), according to findings from the UK Clinical Practice Resea...

Oct 30th, 2019 - Following a safety review, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has concluded that tofacitinib (Xeljanz, Pfizer) could increase the risk of pulmonary embolism (PE) and deep vein thrombosis (...

Sep 10th, 2019 - Venous thromboembolism (VTE) encompasses two interrelated conditions that are part of the same spectrum: deep vein thrombosis (DVT) and pulmonary embolism (PE). PE and DVT can occur in the setting of disease processes, after hospitalization for se...